Cryptogenic organizing pneumonia pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:


===Pathogenesis===
===Pathogenesis===
Various steps in the pathogenesis of cryptogenic organizing pneumonia are:
Various steps in the pathogenesis of [[cryptogenic organizing pneumonia]] are:


1) '''Injury phase''' - The early phase of cryptogenic organizing pneumonia.
1) '''Injury phase''' - The early phase of [[cryptogenic organizing pneumonia]].
*It is characterized by the deposition of plasma proteins in the alveolar lumen.
*It is characterized by the deposition of [[plasma proteins]] in the [[alveolar]] lumen.
*Mechanism of early phase is an imbalance between coagulation and fibrinolytic cascade and activation of coagulation process which leads to fibrin deposition.<ref name="pmid16880372">{{cite journal |vauthors=Cordier JF |title=Cryptogenic organising pneumonia |journal=Eur. Respir. J. |volume=28 |issue=2 |pages=422–46 |date=August 2006 |pmid=16880372 |doi=10.1183/09031936.06.00013505 |url=}}</ref>
*Mechanism of early phase is an imbalance between [[coagulation]] and [[fibrinolytic]] cascade and activation of [[coagulation]] process which leads to [[fibrin]] deposition.<ref name="pmid16880372">{{cite journal |vauthors=Cordier JF |title=Cryptogenic organising pneumonia |journal=Eur. Respir. J. |volume=28 |issue=2 |pages=422–46 |date=August 2006 |pmid=16880372 |doi=10.1183/09031936.06.00013505 |url=}}</ref>


2) '''Proliferating phase''' - The second stage of the cryptogenic organizing pneumonia in which there is a  formation of fibroinflammatory buds.
2) '''Proliferating phase''' - The second stage of the [[cryptogenic organizing pneumonia]] in which there is a  formation of fibro-[[inflammatory]] buds.
* Macrophages and inflammatory cells help in fragmentation of fibrin.
* [[Macrophages]] and [[inflammatory cells]] help in fragmentation of [[fibrin]].
* Activated fibroblasts differentiate into myofibroblasts which are migrating through gaps of the basal lamina.
* Activated [[fibroblasts]] differentiate into [[myofibroblasts]] which are migrating through gaps of the [[basal lamina]].
* Inflammatory cells and fibrin are progressively replaced by aggregated fibroblasts/myofibroblasts intermixed with a loose connective matrix tissue rich in collagen (especially collagen I), fibronectin, procollagen type III and proteoglycans.  
* [[Inflammatory cells]] and [[fibrin]] are progressively replaced by aggregated [[fibroblasts]]/[[myofibroblasts]] intermixed with a [[Loose connective tissue|loose connective]] matrix tissue rich in [[collagen]] (especially collagen I), [[fibronectin]], [[procollagen]] type III and [[proteoglycans]].  
* Alveolar epithelial cells proliferate, restoring the continuity of the alveolar-capillary membrane and the integrity of the alveolar unit.
* [[Alveolar]] [[epithelial cells]] proliferate, restoring the continuity of the [[Alveolar-capillary barrier|alveolar-capillary]] membrane and the integrity of the [[alveolar]] unit.
3) '''Mature phase''' - The third stage is characterized by the formation of  “mature” fibrotic buds.
3) '''Mature phase''' - The third stage is characterized by the formation of  “mature” fibrotic buds.
*In alveolar buds, there are myofibroblasts, organized in concentric rings alternating with layers of collagen bundles.
*In [[alveolar]] buds, there are [[myofibroblasts]], organized in [[concentric]] rings alternating with layers of [[collagen]] bundles.
4)'''Resolution phase''' - The fourth stage, this stage usually resolves if there is the preservation of alveolar basal laminae.
4)'''Resolution phase''' - The fourth stage, this stage usually resolves if there is the preservation of [[alveolar]] basal laminae.


==Associated Conditions==
==Associated Conditions==
Line 31: Line 31:
==Microscopic Pathology==
==Microscopic Pathology==
On microscopic histopathological analysis:<ref name="urlCryptogenic organising pneumonia | Radiology Reference Article | Radiopaedia.org">{{cite web |url=https://radiopaedia.org/articles/cryptogenic-organising-pneumonia-1 |title=Cryptogenic organising pneumonia &#124; Radiology Reference Article &#124; Radiopaedia.org |format= |work= |accessdate=}}</ref>
On microscopic histopathological analysis:<ref name="urlCryptogenic organising pneumonia | Radiology Reference Article | Radiopaedia.org">{{cite web |url=https://radiopaedia.org/articles/cryptogenic-organising-pneumonia-1 |title=Cryptogenic organising pneumonia &#124; Radiology Reference Article &#124; Radiopaedia.org |format= |work= |accessdate=}}</ref>
*It is characterized by chronic mild interstitial inflammation without fibrosis.
*It is characterized by chronic mild interstitial [[inflammation]] without [[fibrosis]].
*There is the formation of buds of granulation tissue which is made of fibrous tissue (Masson bodies),  mononuclear cells and foamy macrophages, in the distal airspaces which cause secondary bronchiolar occlusion due to the presence of the inflammatory process.
*There is the formation of buds of [[granulation tissue]] which is made of [[fibrous tissue]] (Masson bodies),  [[mononuclear cells]] and foamy [[macrophages]], in the distal airspaces which cause [[secondary]] bronchiolar [[occlusion]] due to the presence of the [[inflammatory process]].
[[File:Masson body - high mag.jpg|200px|thumb|centre|Masson body| source:]]
[[File:Masson body - high mag.jpg|200px|thumb|centre| source:]]


==References==
==References==

Revision as of 15:49, 6 March 2018

Cryptogenic Organizing Pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cryptogenic organizing pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Electrocardiogram

Ultrasonography/Echocardiography

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cryptogenic organizing pneumonia pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cryptogenic organizing pneumonia pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cryptogenic organizing pneumonia pathophysiology

CDC on Cryptogenic organizing pneumonia pathophysiology

Cryptogenic organizing pneumonia pathophysiology in the news

Blogs on Cryptogenic organizing pneumonia pathophysiology

Directions to Hospitals Treating Cryptogenic organizing pneumonitis

Risk calculators and risk factors for Cryptogenic organizing pneumonia pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2] Serge Korjian M.D.

Overview

Pathophysiology

Pathogenesis

Various steps in the pathogenesis of cryptogenic organizing pneumonia are:

1) Injury phase - The early phase of cryptogenic organizing pneumonia.

2) Proliferating phase - The second stage of the cryptogenic organizing pneumonia in which there is a formation of fibro-inflammatory buds.

3) Mature phase - The third stage is characterized by the formation of “mature” fibrotic buds.

4)Resolution phase - The fourth stage, this stage usually resolves if there is the preservation of alveolar basal laminae.

Associated Conditions

Gross Pathology

  • On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Microscopic Pathology

On microscopic histopathological analysis:[2]

source:

References

  1. Cordier JF (August 2006). "Cryptogenic organising pneumonia". Eur. Respir. J. 28 (2): 422–46. doi:10.1183/09031936.06.00013505. PMID 16880372.
  2. "Cryptogenic organising pneumonia | Radiology Reference Article | Radiopaedia.org".

Template:WH Template:WS